Rachel Hemple

Market Update: Trump Threatens to Veto C... Stocks ended mixed on Wednesday as investors continued to bet on coming additional stimulus against the ever evolving pandemic. However, Con...

Cybersecurity Sector in Focus Amid Natio... Governments and major corporations worldwide have sounded alarms in the past few days that they have been the victim of a global cyber-espio...

Market Update: Nasdaq Outperforms as Cor... Stocks ended mixed Tuesday as renewed coronavirus concerns outweighed the passage of long-awaited coronavirus fiscal stimulus. Fresh U.S. ec...

New COVID Variant Identified: What's Goi... Over the weekend, England's Health Security Matt Hancock announced that the United Kingdom has identified a new variant of the coronavirus t...

Wish Debut Fails to Wow Investors, Wunon... December closed out the month's initial public offering (IPO) market with another active week last week, with eight traditional IPOs complet...

Market Update: Increased U.K. Lockdowns... Stocks ended Monday's choppy session mixed as renewed coronavirus concerns outweighed ongoing vaccine optimism following increased lockdowns...

Market Update: All Eyes on Additional Co... The broader market fell on Friday as Congressional lawmakers failed to pass additional coronavirus stimulus measures despite bipartisan supp...

California Emerges as New COVID Hotspot The coronavirus outbreak in the United States continues to rage at a record pace ahead of the holiday season, with the nation's current situ...

Market Update: Stimulus Progress Outweig... The broader market rose on Thursday as market participants were encouraged by Washington lawmakers nearly reaching a stimulus deal ahead of...

F.D.A. Authorizes Two COVID Diagnostics... The U.S. Food and Drug Administration (F.D.A.) authorized a rapid coronavirus diagnostics test developed by Abbott Laboratories (NYSE: ABT)...

Market Update: Nasdaq Reaches New Height... Stocks ended Wednesday's session mixed as market participants weighed ongoing stimulus talks and vaccine optimism against the Federal Open M...

Moderna Vaccine One Step Closer to F.D.A... U.S. Food and Drug Administration (F.D.A.) staff endorsed the regulatory approval of Monderan's (NASDAQ: MRNA) coronavirus vaccine candidate...

Market Update: New Two Part Bipartisan S... Stocks rose across the broader market on Tuesday as Congressional lawmakers unveiled a new bipartisan stimulus bill and the Food and Drug Ad...

U.S. Government Expects to Immunize 100... The U.S. government expects to immunize 100 million people with a coronavirus vaccine by the end of March, Operation Warp Speed Chief Adviso...

Market Update: Nasdaq Outperforms as NYC... Stocks ended Monday's session mixed as weighed the roll out of the Pfizer (NYSE: PFE)-BioNTech (NASDAQ: BNTX) vaccine against prolonged Cong...

Wish to Publicly Debut Just in Time for... Following last week's explosive debuts of Airbnb (NASDAQ: ABNB) and DoorDash (NYSE: DASH), the initial public offering (IPO) market has cool...

Airbnb, DoorDash Rank First and Second f... The highly anticipated December initial public offering blowout finally arrived last week, led by the blockbuster debuts of Airbnb and DoorD...

F.D.A. Authorizes Pfizer-BioNTech Vaccin... The Food and Drug Administration (F.D.A.) authorized Pfizer's (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) coronavirus vaccine for emergency us...

U.S. Cannabis Trends Foreshadow Large Em... The United States has recently taken more steps towards the legalization of cannabis, or marijuana, on the federal level. Recently, the Hous...

Market Update: Lengthy Stimulus Talks Di... Wall Street ended Friday's session mixed as Congressional lawmakers continue discussions over additional coronavirus stimulus as daily new i...

Join now and unlock premium features